AlphaCentric Advisors’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

AlphaCentric Advisors’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-81,000	Closed	-$1.18M	–	286
2023 Q1	$1.18M	Hold	81,000	–	–	0.82%	37
2022 Q4	$591K	Buy	81,000 +25,000	+45%	+$176K	0.58%	64
2022 Q3	$388K	Buy	+56,000	New	+$418K	0.4%	67

AlphaCentric Advisors's AMYT Position: Q2 2023 in Review

AlphaCentric Advisors sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 81,000 shares — an estimated $1.18M sold.

AlphaCentric Advisors first reported a position in AMYT in Q3 2022 and held it in 3 quarters. The position peaked at $1.18M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

AlphaCentric Advisors reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
AlphaCentric Advisors sold 81,000 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $1.18M.
AlphaCentric Advisors first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2022 and held it in 3 quarters.
AlphaCentric Advisors's Amryt Pharma plc American Depositary Shares position peaked at $1.18M in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on AlphaCentric Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.